Alnylam Pharmaceuticals
ALNY
#868
Rank
NZ$49.75 B
Marketcap
NZ$371.83
Share price
1.43%
Change (1 day)
-49.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: NZ$833.26 NZD on 2025-10-20

Lowest end of day price: NZ$6.70 NZD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-44.88%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$265.18 1.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$73.72 1.33%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$1,331 1.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$28.46 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.84 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.32 3.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$59.98 1.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$148.68 2.12%๐Ÿ‡บ๐Ÿ‡ธ USA